Zealand Pharma stock sinks 6% in Copenhagen — what investors watch before JPM Healthcare
Zealand Pharma shares dropped 6.1% to 405.5 crowns in Copenhagen by midday Wednesday, sharply underperforming the OMXC25 index’s 0.4% dip. Investors are watching for updates at the J.P. Morgan Healthcare Conference on Jan. 14 and key obesity-drug trial results due in the first half of 2026.
